Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-10-27, Stock:NVS, The news for the past five days is as follows:
2021-10-20: nan
2021-10-21: NEWS1: Novartis Extends Fill/Finish Support For Pfizer/BioNTech COVID-19 Vaccines.
2021-10-22: NEWS1: Regeneron (REGN) Dupixent Meets Goal in Prurigo Nodularis Study.NEWS2: 10 High-Yield Dividend Stocks to Buy According to Ken Fisher.NEWS3: The Zacks Analyst Blog Highlights: Alphabet, Netflix, Thermo Fisher Scientific, Wells Fargo and Novartis.
2021-10-25: NEWS1: Here is What Hedge Funds Think About Novartis AG (NVS).NEWS2: Novartis top-line results for CANOPY-1 Phase III study support further evaluation of canakinumab in lung cancer.
2021-10-26: NEWS1: Novartis Mulls Selling Underperforming Unit As Sales Decline Continues.NEWS2: Novartis (NVS) Q3 2021 Earnings Call Transcript.NEWS3: Novartis (NVS) Q3 Earnings Beat, Sandoz Under Strategic Review.NEWS4: Novartis Boosts Guidance For These Key Drugs After Their Bang-Up Quarter.NEWS5: The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children.NEWS6: Novartis Starts Review of Generic-Drug Unit.NEWS7: Novartis mulls spinning off Sandoz generic drug unit.NEWS8: Novartis May Spin Off or Sell Ailing Sandoz Generics Unit.NEWS9: Novartis may divest generic unit Sandoz as price pressures mount.NEWS10: Novartis delivers solid Q3 results, with strong growth in Innovative Medicines. Announces strategic review of Sandoz.

Answer: Decrease